Soleno wins FDA approval for Prader-Willi hyperphagia treatment
The drug, named Vykat XR, will be available to patients in the US with Prader-Willi syndrome from April 2025.
The drug, named Vykat XR, will be available to patients in the US with Prader-Willi syndrome from April 2025.
What's Your Reaction?
